Pieris Pharmaceuticals PIRS
$ 16.6
4.18%
Quarterly report 2024-Q3
added 11-13-2024
Pieris Pharmaceuticals Cash Flow 2011-2024 | PIRS
Annual Cash Flow Pieris Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-53.8 M | -59.9 M | -7.66 M | -45.9 M | -52.5 M | -1.07 M | 49.8 M | - | - | -15.1 K | - | - | - |
Depreciation & Amortization |
1.9 M | 2.77 M | 2.46 M | 2.1 M | 600 K | 570 K | 369 K | 361 K | 308 K | 367 K | 385 K | - | - |
Accounts Payables |
3.37 M | 4.15 M | 8.61 M | 1.79 M | 5.8 M | 3.35 M | 2.45 M | 2.39 M | 1.06 M | 650 | - | - | - |
Accounts Receivables |
572 K | 5.81 M | 3.31 M | 1.71 M | 6.79 M | 2.7 M | 15.5 M | 57.6 K | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Pieris Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -7 M | - | - | - | -11 M | - | -47 M | - | -22.6 M | - | 3.28 M | - | -12.1 M | - | -32.5 M | -24.9 M | -15.1 M | - | -38.5 M | -25.8 M | -15.1 M | - | 7.99 M | 22.4 M | 31.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | -13.9 K | - | -29.3 K | -948 | -4.51 K | -6.71 K | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | -30 K | - | - | - | 605 K | - | 2.2 M | - | - | - | 1.85 M | - | - | - | - | - | 339 K | - | 367 K | 208 K | 166 K | - | 405 K | 275 K | 134 K | - | 268 K | 213 K | 100 K | - | 175 K | 82.8 K | 94.5 K | - | 234 K | 155 K | 78.1 K | - | 279 K | 189 K | 95.5 K | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
801 K | 969 K | 1.52 M | 3.37 M | 2.82 M | 7.6 M | - | 4.15 M | 3.64 M | - | 4.5 M | 8.61 M | 3.56 M | 2.31 M | 3.47 M | 1.79 M | 1.79 M | 1.79 M | 1.79 M | 5.8 M | 5.8 M | 5.8 M | 5.8 M | 3.35 M | 3.35 M | 3.35 M | 3.35 M | 2.45 M | 2.45 M | 2.45 M | 2.45 M | 2.39 M | 2.39 M | 2.39 M | 2.39 M | 1.06 M | 1.12 M | 1.06 M | 1.06 M | 1.26 M | 650 | 650 | 650 | 278 K | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
373 K | 1.48 M | 1.84 M | 572 K | 1.04 M | 952 K | - | 5.81 M | 829 K | - | 1.64 M | 3.31 M | 6.65 M | 2.8 M | 15.8 M | 1.71 M | 1.71 M | 1.71 M | 1.71 M | 6.79 M | 6.79 M | 6.79 M | 6.79 M | 2.7 M | 2.7 M | 2.7 M | 2.7 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 57 K | 57.6 K | 57.6 K | 57.6 K | - | 17.4 K | - | - | - | - | - | - | 482 K | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency